SOCIETE NEUROLOGIE CLAES
0656.917.256 · rovalta.com · 26/09/2026
ACTIVE
SOCIETE NEUROLOGIE CLAES
Financial year 2025 · Closed on 31/12/2025
Net result26,4 k €+38,4 %over 1 year
Gross margin62,9 k €+29,8 %over 1 year
Equity86,6 k €+41,9 %over 1 year
Overview
Identity
Source · BCE/KBOSOCIETE NEUROLOGIE CLAES is a Private limited company incorporated in 2016. Its main activity is: Specialist medical practice activities. Its registered office is in Rouvroy.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0656.917.256
- Incorporation
- 23/06/2016
- Legal form
- Private limited company
- Registered office
- Rue Escofiette,Torgny 1
6767 Rouvroy · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Joint committees (1)
- 330
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 62,9 k € | +29.8% | 48,5 k € | +77.4% | 27,3 k € | -68.3% | 86,2 k € | -0.1% | 86,3 k € |
| EBITDA | 61,3 k € | +33.2% | 46 k € | +88.2% | 24,5 k € | -70.5% | 83 k € | -0.2% | 83,1 k € |
| Operating result | 38 k € | +61.6% | 23,5 k € | +879% | 2,4 k € | -95.0% | 48 k € | -9.3% | 53 k € |
| Net result | 26,4 k € | +38.4% | 19,1 k € | +557% | -4,2 k € | -114% | 30,6 k € | +30.5% | 23,4 k € |
| Balance sheet | |||||||||
| Equity | 86,6 k € | +41.9% | 61 k € | -12.4% | 69,7 k € | -5.6% | 73,8 k € | -32.5% | 109,4 k € |
| Total assets | 139 k € | -11.9% | 157,7 k € | -9.6% | 174,4 k € | -35.4% | 270,2 k € | -6.6% | 289,2 k € |
| Cash | 109,3 k € | +95.9% | 55,8 k € | -29.1% | 78,7 k € | -53.2% | 168 k € | -4.3% | 175,5 k € |
| Debts | 52,4 k € | -45.8% | 96,7 k € | -7.3% | 104,2 k € | -46.9% | 196,1 k € | +9.1% | 179,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Frédérique Claes
ActiveEnded mandates
Frédérique Claes
EndedFrédérique Claes
EndedFrédérique CLAES
EndedOther companies at this address
Rue Escofiette,Torgny 1 6767 Rouvroy| Company | CBE no. |
|---|---|
ECLIPSE● Active | 0802.755.766 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/07/2021 | 01/07/2020 | 01/07/2019 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 18 months | 12 months | 12 months |
| Filing date | 22/07/2026 | 20/06/2025 | 01/07/2024 | 09/08/2023 | 03/02/2022 | 30/01/2021 |
| General meeting | 23/06/2026 | 09/05/2025 | 27/06/2024 | 26/05/2023 | 23/12/2021 | 24/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 23/06/2026 | 22/07/2026 | French | |
| Micro model | 31/12/2024 | 09/05/2025 | 20/06/2025 | French | |
| Micro model | 31/12/2023 | 27/06/2024 | 01/07/2024 | French | |
| Micro model | 31/12/2022 | 26/05/2023 | 09/08/2023 | French | |
| Micro model | 30/06/2021 | 23/12/2021 | 03/02/2022 | French | |
| Micro model | 30/06/2020 | 24/12/2020 | 30/01/2021 | French | |
| Micro model | 30/06/2019 | 26/12/2019 | 22/01/2020 | French | |
| Micro model | 30/06/2018 | 27/12/2018 | 14/02/2019 | French | |
| Micro model | 30/06/2017 | 28/12/2017 | 19/02/2018 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Frédérique Claes
ActiveEnded mandates
Frédérique Claes
EndedFrédérique Claes
EndedFrédérique CLAES
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office10/07/2026SIEGE SOCIAL
- Mandates04/02/2022STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DIVERS - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Other27/06/2016RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202526,4 k €↑
- 2024Annual accounts 202419,1 k €↑
- 2023Annual accounts 2023-4,2 k €↓
- 2022Annual accounts 202230,6 k €↑
- 2022Name changeSONEUCLA
- 2021Annual accounts 202123,4 k €↑
- 2020Annual accounts 202017,1 k €↓
- 2019Annual accounts 201918,5 k €↓
- 2018Annual accounts 201835,9 k €↑
- 2017Annual accounts 201724,3 k €
- 2017Name changeSOCIETE NEUROLOGIE CLAES
- 23/06/2016IncorporationPrivate limited company